UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Immunomodulation profile of the biosimilar trastuzumab MYL-1401O in a bioequivalence phase I study

Scientific reports, 2024-06, Vol.14 (1), p.12872-12

2024

Volltextzugriff (PDF)

OC005—Biases On The Administered Parenteral Doses Of An Experimental Drug During Phase I Clinical Trials

Clinical therapeutics, 2013-08, Vol.35 (8), p.e2-e3

2013

Volltextzugriff (PDF)

Effects of the dual metallopeptidase inhibitor, MDL 100,240, on regional haemodynamic responses to vasoactive peptides in conscious rats

British journal of pharmacology, 1997-12, Vol.122 (8), p.1687-1693, Article 1687

1997

Volltextzugriff (PDF)

Comparative effects of the dual metallopeptidase inhibitor, MDL 100,240 and of enalaprilat on regional and on cardiac haemodynamics in conscious, hypertensive, transgenic ((mRen‐2)27) rats

British journal of pharmacology, 1997-12, Vol.122 (8), p.1694-1701, Article 1694

1997

Volltextzugriff (PDF)

Comparative Pharmacokinetics of Lovastatin, Simvastatin and Pravastatin in Humans

Journal of clinical pharmacology, 1992-02, Vol.32 (2), p.136-140

1992

Volltextzugriff (PDF)

Effects of a New Selective Estrogen Receptor Modulator (MDL 103,323) on Cancellous and Cortical Bone in Ovariectomized Ewes: A Biochemical, Histomorphometric, and Densitometric Study

Journal of bone and mineral research, 2001-01, Vol.16 (1), p.89-96

2001

Volltextzugriff (PDF)

A single dose of the topical carbonic anhydrase inhibitor MK-927 decreases IOP in patients

British journal of ophthalmology, 1990-07, Vol.74 (7), p.405-408

1990

Volltextzugriff (PDF)

Bioavailability of repeated oral administration of MDL 100,240, a dual inhibitor of angiotensin-converting enzyme and neutral endopeptidase in healthy volunteers

European journal of clinical pharmacology, 2000-01, Vol.55 (10), p.749-754

2000

Volltextzugriff (PDF)

Assessment of bronchial effects following topical administration of butylamino‐phenoxy‐propanol‐acetate, an oculoselective beta‐ adrenoceptor blocker in asthmatic subjects

British journal of clinical pharmacology, 1992-08, Vol.34 (2), p.122-129

1992

Volltextzugriff (PDF)

Whole-blood pharmacokinetics and metabolic effects of the topical carbonic anhydrase inhibitor dorzolamide

European journal of clinical pharmacology, 1995, Vol.47 (5), p.453-460

1995

Volltextzugriff (PDF)

Site of the action of a synthetic atrial natriuretic peptide evaluated in humans

Kidney international, 1987-10, Vol.32 (4), p.537-546

1987

Volltextzugriff (PDF)

Four-Hour Infusions of Synthetic Atrial Natriuretic Peptide in Normal Volunteers

Hypertension (Dallas, Tex. 1979), 1986-06, Vol.8 (6, Part 2 Suppl II), p.II-96-II-105

1986

Volltextzugriff (PDF)

Whole-blood pharmacokinetics and metabolic effects of the topical carbonic anhydrase inhibitor dorzolamide

European journal of clinical pharmacology, 1995, Vol.47 (5), p.455

1995

Volltextzugriff (PDF)

Dose-Dependent Effect of Atrial Natriuretic Peptide on Blood Pressure, Heart Rate, and Skin Blood Flow of Normal Volunteers

Journal of cardiovascular pharmacology, 1986-01, Vol.8 (1), p.216-220

1986

Volltextzugriff (PDF)

Sezolamide: Additivity to timolol twice daily

Eye (London), 1992-01, Vol.6 (5), p.525-529

1992

Volltextzugriff (PDF)

Effects of a dual inhibitor of angiotensin converting enzyme and neutral endopeptidase, MDL 100 240, on endocrine and renal functions in healthy volunteers

Journal of hypertension, 1999-03, Vol.17 (3), p.427-437

1999

Volltextzugriff (PDF)

Comparative tolerability of topical carbonic anhydrase inhibitor MK-927 and its S-enantiomer MK-417

Graefe's archive for clinical and experimental ophthalmology, 1991-01, Vol.229 (2), p.111-114

1991

Volltextzugriff (PDF)

MK-927: a topically effective carbonic anhydrase inhibitor in patients

Archives of ophthalmology (1960), 1989-08, Vol.107 (8), p.1143

1989

Volltextzugriff (PDF)

Atrial natriuretic peptides: reproducibility of renal effects and response of liver blood flow

European journal of clinical pharmacology, 1986, Vol.31 (1), p.1-8

1986

Volltextzugriff (PDF)

Effects of MDL 100,240, a Dual Inhibitor of Angiotensin-Converting Enzyme and Neutral Endopeptidase on the Vasopressor Response to Exogenous Angiotensin I and Angiotensin II Challenges in Healthy Volunteers

Journal of cardiovascular pharmacology, 1998-03, Vol.31 (3), p.408-417

1998

Volltextzugriff (PDF)

Renal Site of the Effect of Atrial Natriuretic Peptide in Normal Volunteers

Journal of cardiovascular pharmacology, 1986-11, Vol.8 (6), p.1302-1302

1986

Volltextzugriff (PDF)

Incremental dosage of the new antipsychotic mazapertine induces tolerance to cardiovascular and cognitive effects in healthy men

Clinical pharmacology and therapeutics, 1996-06, Vol.59 (6), p.675-685

1996

Volltextzugriff (PDF)

Pharmacokinetic and pharmacodynamic profile of icatibant

Clinical pharmacology and therapeutics, 2004-02, Vol.75 (2), p.P56-P56

2004

Volltextzugriff (PDF)

Icatibant has no impact on renal function in healthy subjects

Clinical pharmacology and therapeutics, 2004-02, Vol.75 (2), p.P57-P57

2004

Volltextzugriff (PDF)

The bradykinin antagonist icatibant increases electrolyte and water excretion after sodium challenge in patients with liver cirrhosis

Clinical pharmacology and therapeutics, 2004-02, Vol.75 (2), p.P12-P12

2004

Volltextzugriff (PDF)

1 – 25 von 36

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(30)
Mit Volltextzugriff
(25)

Publikationsform

Artikel
(36)

Sprache

Englisch
(32)
Deutsch
(4)

Erscheinungsjahr

n.n

Thema

Humans
(26)
Male
(25)
Biological And Medical Sciences
(22)
Adult
(21)
Science & Technology
(21)
Life Sciences & Biomedicine
(20)
Medical Sciences
(20)
Pharmacology. Drug Treatments
(20)
Double-Blind Method
(13)
Pharmacology & Pharmacy
(11)
Intraocular Pressure - Drug Effects
(10)
Blood Pressure - Drug Effects
(7)
Cardiovascular System
(7)
Eye
(7)
Female
(7)
Ophthalmic Solutions
(7)
Sulfonamides - Administration & Dosage
(7)
Thiophenes - Administration & Dosage
(7)
Administration, Topical
(6)
Heart Rate - Drug Effects
(6)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Immunomodulation profile of the biosimilar trastuzumab MYL-1401O in a bioequivalence phase I study

OC005—Biases On The Administered Parenteral Doses Of An Experimental Drug During Phase I Clinical Trials

Effects of the dual metallopeptidase inhibitor, MDL 100,240, on regional haemodynamic responses to vasoactive peptides in conscious rats

Comparative effects of the dual metallopeptidase inhibitor, MDL 100,240 and of enalaprilat on regional and on cardiac haemodynamics in conscious, hypertensive, transgenic ((mRen‐2)27) rats

Comparative Pharmacokinetics of Lovastatin, Simvastatin and Pravastatin in Humans

Effects of a New Selective Estrogen Receptor Modulator (MDL 103,323) on Cancellous and Cortical Bone in Ovariectomized Ewes: A Biochemical, Histomorphometric, and Densitometric Study

A single dose of the topical carbonic anhydrase inhibitor MK-927 decreases IOP in patients

Bioavailability of repeated oral administration of MDL 100,240, a dual inhibitor of angiotensin-converting enzyme and neutral endopeptidase in healthy volunteers

Assessment of bronchial effects following topical administration of butylamino‐phenoxy‐propanol‐acetate, an oculoselective beta‐ adrenoceptor blocker in asthmatic subjects

Whole-blood pharmacokinetics and metabolic effects of the topical carbonic anhydrase inhibitor dorzolamide

Site of the action of a synthetic atrial natriuretic peptide evaluated in humans

Four-Hour Infusions of Synthetic Atrial Natriuretic Peptide in Normal Volunteers

Whole-blood pharmacokinetics and metabolic effects of the topical carbonic anhydrase inhibitor dorzolamide

Dose-Dependent Effect of Atrial Natriuretic Peptide on Blood Pressure, Heart Rate, and Skin Blood Flow of Normal Volunteers

Sezolamide: Additivity to timolol twice daily

Effects of a dual inhibitor of angiotensin converting enzyme and neutral endopeptidase, MDL 100 240, on endocrine and renal functions in healthy volunteers

Comparative tolerability of topical carbonic anhydrase inhibitor MK-927 and its S-enantiomer MK-417

MK-927: a topically effective carbonic anhydrase inhibitor in patients

Atrial natriuretic peptides: reproducibility of renal effects and response of liver blood flow

Effects of MDL 100,240, a Dual Inhibitor of Angiotensin-Converting Enzyme and Neutral Endopeptidase on the Vasopressor Response to Exogenous Angiotensin I and Angiotensin II Challenges in Healthy Volunteers

Renal Site of the Effect of Atrial Natriuretic Peptide in Normal Volunteers

Incremental dosage of the new antipsychotic mazapertine induces tolerance to cardiovascular and cognitive effects in healthy men

Pharmacokinetic and pharmacodynamic profile of icatibant

Icatibant has no impact on renal function in healthy subjects

The bradykinin antagonist icatibant increases electrolyte and water excretion after sodium challenge in patients with liver cirrhosis

Suchergebnisse filtern